STAT+: FTC slams PBMs for boosting specialty drug prices at the expense of the U.S. health care system
STAT
JANUARY 14, 2025
For the second time in less than a year, the U.S. Federal Trade Commission released a highly critical report of pharmacy benefit managers, which play a crucial but opaque role in the pharmaceutical supply chain. And the findings may provide further impetus for legislative action to curb practices that critics say contribute to the rising cost of prescription drugs.
Let's personalize your content